Education
About Us
Working with TipRanks
Follow Us
Richard Klausner Insider Profile
11 Followers
Richard Klausner, Sr VP, Chief Medical Officer at Illumina, holds 3.81M shares in Lyell Immunopharma (Ticker: LYEL), holds 0.00 shares in Juno Therapeutics (Ticker: JUNO), holds 22.85K shares in Illumina (Ticker: ILMN). Most recently, Richard Klausner Bought ― shares of Lyell Immunopharma on Mar 18, 2025 for an estimated value of 94.80K.
Richard Klausner Illumina (ILMN)Sr VP, Chief Medical Officer
Illumina (ILMN)
Sr VP, Chief Medical Officer
Ranked #19,353 out of 102,551 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+41.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Richard Klausner holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Sep 27, 2022 - Sep 27, 2023
Return:+77.30%
The most profitable trade made by Richard Klausner
Richard Klausner's Trading History
Illumina
Feb 01, 2016
Sr VP, Chief Medical Officer
Uninformative Sell
39.96K
$2.20M
Lyell Immunopharma
Mar 18, 2025
Director
Informative Buy
94.80K
$35.22M
Juno Therapeutics
Mar 07, 2018
―
Uninformative Sell
61.38M
$0.00
List of latest transactions for each holding click on a transaction to see Richard Klausner's performance on stock
You May Also Like
Richard Klausner insider profile FAQ
What is the percentage of profitable transactions made by Richard Klausner?
The percentage of profitable transactions made by Richard Klausner is 100%.
What is the average return per transaction made by Richard Klausner?
The average return per transaction made by Richard Klausner is 41.10%.
What stocks does Richard Klausner hold?
Richard Klausner holds: ILMN, LYEL, JUNO stocks.
What was Richard Klausner’s latest transaction?
Richard Klausner latest transaction was an Informative Buy of $94.80K.
What was Richard Klausner's most profitable transaction?
Richard Klausner’s most profitable transaction was an Informative Sell of LYEL stock on September 27, 2022. The return on the trade was 77.30%.
What is Richard Klausner's role in Illumina?
Richard Klausner's role in Illumina is Sr VP, Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.